Back
ESC Professional Premium Access

Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry

Session: Epidemiological aspects of atrial fibrillation
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor W. Ding (Liverpool, GB)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Wern Yew Ding

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
0 follower

5 more presentations in this session

Changes in incidences of clinical outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study since 2010.

Speaker: Professor L. Fauchier (Tours, FR)

Access
Abstract
Slides
Like
Thumbnail

Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: Data from PREVEND

Speaker: Mr A. Al Mubarak (Groningen, NL)

Access
Abstract
Slides
Like
Thumbnail

Bone morphogenetic protein 10 as predictor for adverse outcomes in patients with atrial fibrillation

Speaker: Doctor E. Hennings (Basel, CH)

Access
Abstract
Slides
Like
Thumbnail

Impact of the atrial fibrillation better care pathway in clinically complex patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF General Long-Term Registry

Speaker: Doctor G. Romiti (Rome, IT)

Access
Abstract
Slides
Like
Thumbnail

Prediction of incident atrial fibrillation with GDF-15 and echocardiographic left atrial volumes: data from the Akershus cardiac examination 1950 study

Speaker: Doctor P. Roenningen (Baerum, NO)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Epidemiological aspects of atrial fibrillation

Speakers: Doctor W. Ding, Professor L. Fauchier, Mr A. Al Mubarak, Doctor E. Hennings, Doctor G. Romiti...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources